These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 35931652)
1. Chemotherapy effectiveness and age-group analysis of older adult patients with metastatic pancreatic cancer: A Japanese cancer registry cohort study. Daiku K; Ikezawa K; Morishima T; Kai Y; Takada R; Yamai T; Miyashiro I; Ohkawa K J Geriatr Oncol; 2022 Nov; 13(8):1208-1215. PubMed ID: 35931652 [TBL] [Abstract][Full Text] [Related]
2. An age-group analysis on the efficacy of chemotherapy in older adult patients with metastatic biliary tract cancer: a Japanese cancer registry cohort study. Hirao T; Ikezawa K; Morishima T; Daiku K; Seiki Y; Watsuji K; Kawamoto Y; Higashi S; Urabe M; Kai Y; Takada R; Yamai T; Mukai K; Nakabori T; Uehara H; Miyashiro I; Ohkawa K BMC Gastroenterol; 2023 Aug; 23(1):263. PubMed ID: 37528334 [TBL] [Abstract][Full Text] [Related]
3. Hospital volume and prognosis of patients with metastatic pancreatic cancer: A study using the Osaka Cancer Registry. Kawamoto Y; Ikezawa K; Tabuchi T; Morishima T; Seiki Y; Watsuji K; Hirao T; Higashi S; Urabe M; Kai Y; Takada R; Yamai T; Mukai K; Nakabori T; Uehara H; Miyashiro I; Ohkawa K J Cancer Res Clin Oncol; 2023 Nov; 149(14):12835-12841. PubMed ID: 37462770 [TBL] [Abstract][Full Text] [Related]
4. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study. Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959 [TBL] [Abstract][Full Text] [Related]
5. Irreversible electroporation after induction chemotherapy versus chemotherapy alone for patients with locally advanced pancreatic cancer: A propensity score matching analysis. He C; Wang J; Zhang Y; Lin X; Li S Pancreatology; 2020 Apr; 20(3):477-484. PubMed ID: 32131993 [TBL] [Abstract][Full Text] [Related]
6. Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. Xie H; Liu J; Ogden JR; Yin J; Jatoi A; Hubbard JM; McWilliams RR; Mahipal A; Petersen GM; Bekaii-Saab TS; Ma WW Am J Clin Oncol; 2020 Aug; 43(8):586-590. PubMed ID: 32349022 [TBL] [Abstract][Full Text] [Related]
7. Use and outcomes of chemotherapy for metastatic pancreatic cancer in Australia. Body A; Wong R; Shapiro J; Jalali A; McLachlan SA; Ananda S; Lipton L; Cooray P; Gibbs P; Lee B; Lee M Intern Med J; 2022 Jan; 52(1):49-56. PubMed ID: 33040452 [TBL] [Abstract][Full Text] [Related]
8. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis. Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114 [TBL] [Abstract][Full Text] [Related]
9. Ten weeks to live: a population-based study on treatment and survival of patients with metastatic pancreatic cancer in the south of the Netherlands. Bernards N; Haj Mohammad N; Creemers GJ; de Hingh IH; van Laarhoven HW; Lemmens VE Acta Oncol; 2015 Mar; 54(3):403-10. PubMed ID: 25263080 [TBL] [Abstract][Full Text] [Related]
10. Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting. Kostos L; Hong W; Lee B; Tran B; Lok SW; Anton A; Gard G; To YH; Wong V; Shapiro J; Wong R; Wong S; de Boer R; Gibbs P Int J Cancer; 2021 Jul; 149(2):409-419. PubMed ID: 33729581 [TBL] [Abstract][Full Text] [Related]
11. Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone. Ramaswamy K; Lechpammer S; Mardekian J; Huang A; Schultz NM; Sandin R; Wang L; Baser O; George DJ Adv Ther; 2020 May; 37(5):2083-2097. PubMed ID: 32112280 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of carcinoembryonic antigen (CEA) on patients with metastatic pancreatic cancer: A retrospective cohort study. Imaoka H; Mizuno N; Hara K; Hijioka S; Tajika M; Tanaka T; Ishihara M; Hirayama Y; Hieda N; Yoshida T; Okuno N; Shimizu Y; Niwa Y; Yamao K Pancreatology; 2016; 16(5):859-64. PubMed ID: 27256641 [TBL] [Abstract][Full Text] [Related]
13. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study. Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022 [TBL] [Abstract][Full Text] [Related]
14. Long-term survival analysis of sublobar resection versus lobectomy for older patients with early-stage pulmonary carcinoid tumour: a database-based propensity score-matched study. Yang H; Xiao X; Mei T; Zhou P Aging Clin Exp Res; 2022 Aug; 34(8):1925-1934. PubMed ID: 35347580 [TBL] [Abstract][Full Text] [Related]
15. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data]. Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769 [No Abstract] [Full Text] [Related]
16. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis. Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208 [TBL] [Abstract][Full Text] [Related]
17. Early-onset pancreatic cancer: a population-based study using the SEER registry. Ansari D; Althini C; Ohlsson H; Andersson R Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855 [TBL] [Abstract][Full Text] [Related]
18. Survival benefit of thermal ablation combined with chemotherapy for the treatment of stage IV nonsmall cell lung cancer: a propensity-matched analysis. Yang H; Li M; Mei T Int J Hyperthermia; 2022; 39(1):348-357. PubMed ID: 35164638 [TBL] [Abstract][Full Text] [Related]
19. Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study. Moriwaki T; Fukuoka S; Taniguchi H; Takashima A; Kumekawa Y; Kajiwara T; Yamazaki K; Esaki T; Makiyama C; Denda T; Satake H; Suto T; Sugimoto N; Enomoto M; Ishikawa T; Kashiwada T; Sugiyama M; Komatsu Y; Okuyama H; Baba E; Sakai D; Watanabe T; Tamura T; Yamashita K; Gosho M; Shimada Y Oncologist; 2018 Jan; 23(1):7-15. PubMed ID: 28894015 [TBL] [Abstract][Full Text] [Related]